Avedro VibeX gets FDA orphan drug status
Avedro’s KXL, VibeX and Keraflex are CE marked and are commercially available outside of the US. Currently, the company has filed an additional application for orphan drug designation
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.